VanEck Associates’s Taubman Centers Inc. TCO Stock Holding History

VanEck Associates’s Portfolio TCO Stock Details TCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,820	Closed	-$61K	–	1050
2020 Q3	$61K	Buy	1,820 +346	+23%	+$12.9K	﹤0.01%	922
2020 Q2	$56K	Buy	1,474 +756	+105%	+$30.9K	﹤0.01%	902
2020 Q1	$30K	Buy	718 +374	+109%	+$15.6K	﹤0.01%	902
2019 Q4	$11K	Buy	+344	New	+$11.8K	﹤0.01%	956
2019 Q1	–	Sell	-12,816	Closed	-$583K	–	871
2018 Q4	$583K	Buy	12,816 +1,031	+9%	+$54.1K	﹤0.01%	627
2018 Q3	$705K	Buy	11,785 +569	+5%	+$35.1K	﹤0.01%	631
2018 Q2	$659K	Buy	+11,216	New	+$630K	﹤0.01%	637

Other funds holding TCO

MMEA

MEAG MUNICH ERGO AssetManagement Munich, Germany $162K AUM 21.36% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

VanEck Associates's TCO Position: Q4 2020 in Review

VanEck Associates sold out of Taubman Centers Inc. (TCO) in Q4 2020, closing a stake of 1,820 shares — an estimated $61K sold.

VanEck Associates first reported a position in TCO in Q2 2018 and held it in 7 quarters. The position peaked at $705K in Q3 2018. 4 funds tracked by Wall St. Rank hold TCO as of Q4 2020.

VanEck Associates reported no remaining Taubman Centers Inc. position as of Q4 2020 after selling out during the quarter.
VanEck Associates sold 1,820 Taubman Centers Inc. shares in Q4 2020, an estimated $61K.
VanEck Associates first reported a position in Taubman Centers Inc. in Q2 2018 and held it in 7 quarters.
VanEck Associates's Taubman Centers Inc. position peaked at $705K in Q3 2018.
4 funds tracked by Wall St. Rank held Taubman Centers Inc. as of Q4 2020.

Based on VanEck Associates's 13F filing for Q4 2020, filed 9 Feb 2021.